Struthers Richard Scott 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Sep 30, 2025
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-09-26$45.00/sh−4,000$180,000→ 106,000 total(indirect: By Trust)
Holdings
- 661,205(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 320,017
Common Stock
- 100,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $45.00 per share.